Understanding the Key Differences Between PSUR and DSUR in Pharmacovigilance
- temidayodada
- Jan 3
- 2 min read
Drug safety isn’t assessed in the same way throughout a medicine’s life. That idea took me a while to properly grasp – and it’s exactly why two safety reports that sound very similar, PSUR and DSUR, both exist. Once I understood when each one is used, the distinction finally clicked.
What is a PSUR?
A PSUR is a document that pharmaceutical companies submit regularly after a drug has been authorized for marketing. Its main goal is to provide an updated evaluation of the drug’s safety profile based on all available data since the last report. This includes adverse event reports, clinical trial results, and scientific literature.
Key Features of PSUR
Timing: Submitted at defined intervals, often every six months or annually, depending on regulatory requirements.
Scope: Covers all safety information for a marketed product.
Purpose: To monitor the benefit-risk balance of the drug over time and identify any new safety concerns.
Audience: Regulatory authorities who oversee marketed drugs.
For example, a company marketing a new diabetes medication will submit PSURs to regulators to show ongoing safety monitoring and any new findings that might affect patient use.
What is a DSUR?
The DSUR focuses on investigational drugs still in clinical development. It provides a comprehensive safety update during the trial phase, summarizing adverse events and other safety data collected from ongoing studies.
Key Features of DSUR
Timing: Submitted annually during the clinical trial period.
Scope: Includes safety data from all clinical trials for the investigational product.
Purpose: To ensure patient safety during development and support regulatory decisions about continuing trials.
Audience: Regulatory bodies overseeing clinical trials.
For instance, a pharmaceutical company testing a new cancer drug will submit DSURs to report safety findings from phase 1, 2, and 3 trials, helping regulators assess risks before approval.
Main Differences Between PSUR and DSUR
This framing helped me remember it clearly:
DSUR → development stage, before approval
PSUR → post-approval, real-world use
Same safety mindset – different point in the lifecycle.
Why Both Reports Matter
Both PSUR and DSUR contribute to patient safety but at different points:
DSURs help identify risks early during drug development, allowing adjustments to trial protocols or stopping trials if necessary.
PSURs track long-term safety after the drug reaches patients, capturing rare or delayed adverse effects.
Together, they form a continuous safety monitoring system that protects public health.
Final Thoughts
Understanding the difference between PSURs and DSURs helped me see how carefully safety oversight is layered across a medicine’s life. Rather than feeling bureaucratic, these reports feel like checkpoints –ensuring decisions remain justified as new data becomes available. It’s one of the clearest examples I’ve seen of regulation adapting over time.
